Month: September 2018

FluView-ILI & SARI Surveillance Report for Week 38, 2018

The overall incidence of Influenza-Like-Illness (ILI) and Severe Acute Respiratory Infection (SARI) were 26/1000 outpatient visits and 7/100 hospitalized patients respectively. None of the samples tested positive for influenza virus (Figure 1). Fluview Week 38

This was posted on Thursday, September 27th, 2018 By in Report , .

FluView-ILI & SARI Surveillance Report for Week 37, 2018

The predominant seasonal Influenza strain circulated in the week was Influenza A/H3. The overall incidence of Influenza-Like-Illness (ILI) and Severe Acute Respiratory Infection (SARI) were 26/1000 outpatient visits and 8/100 hospitalized patients respectively. The most laboratory-confirmed affected age group belonged to 2–4 years and 15-29 years age group among ILI cases, and 30-64 years age… [Read more]

This was posted on Thursday, September 27th, 2018 By in Report , .

FluView-ILI & SARI Surveillance Report for Week 36, 2018

The overall incidence of Influenza-Like-Illness (ILI) and Severe Acute Respiratory Infection (SARI) were 50/1000 outpatient visits and 9/100 hospitalized patients respectively. Both ILI and SARI samples were negative for influenza virus (Figure 1). Fluview Week 36

This was posted on Thursday, September 13th, 2018 By in Report , .

Monthly Epidemiology Report for August 2018

Of five AES cases; three were reported from JDWNRH, one from CRRH and One from MRRH. All five cases were in the age group of 1-11 months. Four cases of Bacterial meningitis, two from JDWNRH, one from Gedu and one from CRRH were reported. All were above the age of 15 years. 36 suspected measles… [Read more]

This was posted on Thursday, September 6th, 2018 By in Report , .

FluView-ILI & SARI Surveillance Report for Week 35, 2018

The predominant seasonal Influenza strain circulated in the week was Influenza A/H3. The overall incidence of Influenza-Like-Illness (ILI) and Severe Acute Respiratory Infection (SARI) were 36/1000 outpatient visits and 8/100 hospitalized patients respectively. The most laboratory-confirmed affected age group belonged to 2– 4 and 15 – 29 years age group (Figure 1). Fluview Week 35

This was posted on Thursday, September 6th, 2018 By in Report , .